sk, while "Race with Insulin" is a sponsored branded Twitter page, where he can also tweet about the insulin he uses.
Kimball, who began racing go-karts at age 9, chose to bypass admission to Stanford University to follow his dream to become a racecar driver. When he was diagnosed with diabetes in 2007 he was forced to abandon his racing program mid-season. Remarkably in 2008, Kimball returned to the cockpit and claimed a podium finish in his first race back in the car. Recently he recorded his fourth top 10 finish in Iowa, continuing to prove that his high performance life is possible with diabetes.
Kimball was first introduced to Novo Nordisk when his physician prescribed Novo Nordisk insulins Levemir® (insulin detemir rDNA origin injection) and NovoLog® (insulin aspart [rDNA origin injection) when he was diagnosed.
Last year, he approached Novo Nordisk about becoming a sponsor and the company has had its APIS bull, Levemir® and NovoLog® logos on his fire suit, and helmet since April 2009 and on the car since May 2009. Since the partnership began, Kimball has done a series of speaking engagements across the country talking about pursuing his passion and diabetes management.
"Charlie is an inspiration to anyone with diabetes," said Craig DeLarge, associate director of e-Marketing at Novo Nordisk. "We hope that by providing Charlie an interactive platform to share his message, we can motivate patients and healthcare providers to learn more about ways to dialogue about health care."
Novo Nordisk and Charlie Kimball are committed to ensuring compliance with all laws and regulations, including the PhRMA organization guidance on direct to consumer advertising. Important safety information about Levemir® and NovoLog® is located on the left side of the "Race with Insulin" home page. Whenever Kimball discusses either Levemir® or NovoLog®, he will in
'/>"/>
Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
Novo Nordisk Insulin Analogs Have Proven Safety Profiles2.
Novo Nordisk Warns Customers About Stolen Insulin3.
Diabetes Experts Partner With Novo Nordisk to Provide New Patient Materials4.
Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S.5.
Novo Nordisk Appoints Andy Ajello as Vice President for National Diabetes Sales, Managed Care and Government Accounts6.
Novo Nordisk Makes its Debut in FORTUNEs 100 Best Companies to Work For7.
Novo Nordisk Changing Diabetes(R) Bus Boogies into San Francisco on World Tour to Beat Diabetes8.
FDA Approves NOVO NORDISKs NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors9.
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President10.
Novo Nordisk Files Annual Report with the SEC11.
Novo Nordisk Increased Net Profit by 32% in 2007